1. Home
  2. HRMY vs DSGR Comparison

HRMY vs DSGR Comparison

Compare HRMY & DSGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRMY
  • DSGR
  • Stock Information
  • Founded
  • HRMY 2017
  • DSGR 1952
  • Country
  • HRMY United States
  • DSGR United States
  • Employees
  • HRMY N/A
  • DSGR N/A
  • Industry
  • HRMY Biotechnology: Pharmaceutical Preparations
  • DSGR Industrial Machinery/Components
  • Sector
  • HRMY Health Care
  • DSGR Industrials
  • Exchange
  • HRMY Nasdaq
  • DSGR Nasdaq
  • Market Cap
  • HRMY 2.0B
  • DSGR 1.8B
  • IPO Year
  • HRMY 2020
  • DSGR N/A
  • Fundamental
  • Price
  • HRMY $39.05
  • DSGR $34.30
  • Analyst Decision
  • HRMY Strong Buy
  • DSGR Buy
  • Analyst Count
  • HRMY 8
  • DSGR 2
  • Target Price
  • HRMY $55.00
  • DSGR $43.00
  • AVG Volume (30 Days)
  • HRMY 593.9K
  • DSGR 61.7K
  • Earning Date
  • HRMY 02-20-2025
  • DSGR 03-06-2025
  • Dividend Yield
  • HRMY N/A
  • DSGR N/A
  • EPS Growth
  • HRMY N/A
  • DSGR N/A
  • EPS
  • HRMY 2.11
  • DSGR 0.04
  • Revenue
  • HRMY $681,879,000.00
  • DSGR $1,728,880,000.00
  • Revenue This Year
  • HRMY $24.79
  • DSGR $16.08
  • Revenue Next Year
  • HRMY $19.00
  • DSGR $12.01
  • P/E Ratio
  • HRMY $18.55
  • DSGR $709.92
  • Revenue Growth
  • HRMY 25.83
  • DSGR 15.72
  • 52 Week Low
  • HRMY $28.14
  • DSGR $28.01
  • 52 Week High
  • HRMY $41.61
  • DSGR $41.47
  • Technical
  • Relative Strength Index (RSI)
  • HRMY 71.30
  • DSGR 40.63
  • Support Level
  • HRMY $35.72
  • DSGR $33.80
  • Resistance Level
  • HRMY $37.16
  • DSGR $34.85
  • Average True Range (ATR)
  • HRMY 1.29
  • DSGR 1.28
  • MACD
  • HRMY 0.48
  • DSGR 0.10
  • Stochastic Oscillator
  • HRMY 92.25
  • DSGR 44.88

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.

About DSGR Distribution Solutions Group Inc.

Distribution Solutions Group Inc is an industrial distributor of maintenance and repair supplies. It has three operating segments namely Lawson, TestEquity, and Gexpro Services, of which key revenue is derived from the TestEquity segment. The TestEquity segment is a distributor of test and measurement equipment and solutions, electronic production supplies, and tool kits from its manufacturer partners supporting the technology, aerospace, defense, automotive, electronics, education, and medical industries.

Share on Social Networks: